Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating expenses:
Research and development	$ 25,347	$ 18,242	$ 71,680	$ 42,174
General and administrative	5,772	5,242	17,127	15,184
Total operating expenses	31,119	23,484	88,807	57,358
Loss from operations	(31,119)	(23,484)	(88,807)	(57,358)
Interest and other income, net	2,690	594	6,436	844
Net loss	(28,429)	(22,890)	(82,371)	(56,514)
Other comprehensive loss:
Unrealized gain (loss) on investments, net		4		(3)
Comprehensive loss	$ (28,429)	$ (22,886)	$ (82,371)	$ (56,517)
Net loss per common share, basic	$ (0.8)	$ (0.78)	$ (2.46)	$ (1.93)
Net loss per common share, diluted	$ (0.8)	$ (0.78)	$ (2.46)	$ (1.93)
Weighted-average number of common shares used to compute basic net loss per common share	35,653,988	29,319,042	33,551,808	29,214,549
Weighted-average number of common shares used to compute diluted net loss per common share	35,653,988	29,319,042	33,551,808	29,214,549